Financhill
Back

LifeMD Quote, Financials, Valuation and Earnings

Sell
29

LFMD
LifeMD

Last Price:
7.76
Seasonality Move:
31.41%

7 Day Trial

ALL ACCESS PASS

$ 7

LifeMD Price Quote

$7.76
-0.01 (0.52%)
(Updated: May 18, 2024 at 5:47 AM ET)

LifeMD Key Stats

Sell
29
LifeMD (LFMD) is a Sell

Day range:
$7.73 - $8.04
52-week range:
$1.81 - $12.88
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.70
P/B ratio:
0%

Volume:
826.4K
Avg. volume:
818.6K
1-year change:
315.51%
Market cap:
$328.6M
Revenue:
$152.5M
EPS:
$-0.74

How Much Does LifeMD Make?

  • How Much Are LifeMD's Sales Annually?
    LFMD Revenues are $152.5M
  • How Much Profit Does LifeMD's Make A Year?
    LFMD net income is -$20.6M

Is LifeMD Growing As A Company?

  • What Is LifeMD's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.33%
  • What Is LifeMD's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

LifeMD Stock Price Performance

  • Did LifeMD Stock Go Up Last Month?
    LifeMD share price went down by -21.28% last month
  • Did LFMD's Share Price Rise Over The Last Year?
    LFMD share price rose by 315.51% over the past 1 year

What Is LifeMD 52-Week High & Low?

  • What Is LifeMD’s 52-Week High Share Price?
    LifeMD has traded as high as $12.88 over the past 52 weeks
  • What Is LifeMD’s 52-Week Low Share Price?
    LifeMD has traded as low as $1.81 over the past 52 weeks

LifeMD Price To Free Cash Flow

  • Is LifeMD Stock Overvalued?
    LifeMD is trading at a price to free cash flow ratio of 36.92
  • Is LifeMD Stock Undervalued?
    LifeMD EV to Free Cash Flow ratio is 41.70
  • What Is LifeMD’s Price Earnings Growth Ratio?
    LFMD PEG ratio is 0.00
  • Is LifeMD Trading At A Premium To Earnings?
    LifeMD EV to EBIT ratio is 0.00

Is It Risky To Buy LifeMD?

  • How Much Debt Does LifeMD Have?
    Total long term debt quarterly is $18.1M
  • How Much Cash Does LifeMD Have?
    Cash and short term investments quarterly total is $35.1M
  • What Is LifeMD’s Book Value Per Share?
    Book value per share is -0.02

Is LifeMD Cash Flow Positive?

  • What Is LFMD Cash Flow From Operations?
    Cash flow from operations (TTM) is $16.6M
  • What Is LifeMD’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $16.1M
  • What Is LifeMD’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$9.1M

LifeMD Return On Invested Capital

  • Is Management Doing A Good Job?
    LFMD return on invested capital is -184.23%
  • What Is LifeMD Return On Assets?
    ROA measures how assets are converting to revenues and is -50.79%
  • What Is LFMD Return On Equity?
    ROE is a measure of profitability and is 0%

LifeMD Earnings Date & Stock Price

  • What Is LifeMD's Stock Price Today?
    A single share of LFMD can be purchased today for 7.77
  • What Is LifeMD’s Stock Symbol?
    LifeMD trades on the nasdaq under the ticker symbol: LFMD
  • When Is LifeMD’s Next Earnings Date?
    The next quarterly earnings date for LifeMD is scheduled on August 9, 2024
  • When Is LFMD's next ex-dividend date?
    LifeMD's next ex-dividend date is May 18, 2024
  • How To Buy LifeMD Stock?
    You can buy LifeMD shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

LifeMD Competitors

  • Who Are LifeMD's Competitors?
    Below is a list of companies who compete with LifeMD or are related in some way:
    • LENZ Therapeutics Inc (LENZ)
    • Veradigm Inc (MDRX)
    • PetMed Express Inc (PETS)
    • Streamline Health Solutions Inc (STRM)
    • TruBridge Inc (TBRG)

LifeMD Dividend Yield

Data Unavailable

LifeMD Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 200%
Revenue: 33.26% 3.66%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 13.00
Upside from Last Price: 67.31%

Major Shareholders

  • How many LFMD shares are owned by institutional investors?
    15.4M LFMD shares are owned by institutional investors
  • How many LFMD shares are owned by insiders?
    9.6M LFMD shares are owned by insiders